OxyContin Patent Settlement Could Mean No Generics Come 2008
This article was originally published in The Pink Sheet Daily
Purdue reaches agreement with final generic manufacturer of extended-release oxycodone.
You may also be interested in...
As part of settlement agreements with Purdue Pharma, Endo and Teva agree to stop selling generic versions of the pain medication.
CEO Clozel discusses the firm’s renin inhibitor program in the face of Novartis’ Tekturna, alliances with Merck and Roche and its business strategy going forward.
Exec discusses the firm’s pulmonary arterial hypertension drug Tracleer and other endothelin receptor antagonists in Actelion’s pipeline.